Travere Therapeutics
TVTX
$5.51
Share price
0.92%
Change (1 day)
-75.63%
Change (1 year)
Categories
Travere Therapeutics (TVTX) - P/B ratio
P/B ratio as of April 2024 : 2.07
According to Travere Therapeutics's latest financial reports the company has a price-to-book ratio of 2.07.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Travere Therapeutics - P/B ratio (from 2011 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.36 | -89.32% |
| 2022-12-31 | 31.5 | 400.66% |
| 2021-12-31 | 6.29 | -6.7% |
| 2020-12-31 | 6.74 | 143.74% |
| 2019-12-31 | 2.77 | -6.01% |
| 2018-12-31 | 2.94 | 4.17% |
| 2017-12-31 | 2.83 | 21.74% |
| 2016-12-31 | 2.32 | -1.03% |
| 2015-12-31 | 2.34 | -127.4% |
| 2014-12-31 | -8.56 | 30.58% |
| 2013-12-31 | -6.55 | -98.58% |
| 2012-12-31 | -463 | 29756.2% |
| 2011-12-31 | -1.55 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6221 | -69.94% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -5.34% | 🇺🇸 USA |